Dr. Gage is chairman of the board of directors at Cytokinetics and from 1998 to 2002 served as President of Wyeth Research and subsequently Senior Vice President, Science and Technology. From 1989 to 1998, he held roles of increasing responsibility at Genetics Institute, Inc., first as head of Research and Development, then as Chief Operating Officer, and eventually as President. From 1971 to 1989, Dr. Gage held various positions in research management with Hoffmann-La Roche Inc., most recently serving as Vice President responsible for U.S. drug discovery. Dr. Gage has served as the Chairman of the Board of Directors of Tetraphase Pharmaceuticals since April 2013. Dr. Gage served on the Board of Directors of Neose Technologies from 2002 to 2009, and as the Chairman of its Board of Directors from 2006 to 2009. He served on PDL BioPharma, Inc.’s Board of Directors from 2003 to 2008, as the Chairman of its Board of Directors in 2007, and as its Interim Chief Executive Officer from 2007 to 2008. Dr. Gage earned a bachelor’s degree in Physics from the Massachusetts Institute of Technology and a Ph.D. in Biophysics from the University of Chicago.